Le Lézard
Classified in: Transportation, Science and technology, Business
Subjects: CON, TRD

Southfield Capital Partners with Alba Wheels Up


GREENWICH, Conn., March 16, 2021 /PRNewswire/ -- Southfield Capital, a premier lower middle market private equity firm, announced today its partnership with Alba Wheels Up ("Alba" or the "Company"), a logistics services company providing customs brokerage, freight forwarding, and other related services for U.S. importers and exporters. The Company's owners, Salvatore and Damien Stile, will remain in their existing leadership roles post-close. The Alba partnership represents the first platform investment from Southfield Capital III LP.

Alba provides customs brokerage, freight forwarding, trade compliance and other logistics services across key end markets, including apparel and accessories, pharmaceuticals, industrial, and food and drugs. The Company enables its clients to efficiently import and export goods to and from the United States and properly navigate the complex logistics landscape. Alba leverages its extensive regulatory and customs knowledge along with its logistical network of carriers and agents to ensure goods are moved expeditiously and accurately. Alba is headquartered in Valley Stream, NY, and has additional offices in California, New Jersey and Texas.

"We are excited to partner with Southfield and believe this partnership will enable Alba to accelerate growth and expand our reach and capabilities for our clients. With Southfield's resources, capital and support we will be able to expand our service offerings, enter new markets, strengthen our technology platform and continue our leadership in Section 321 and e-commerce. We have developed a strong relationship with the Southfield team over the last few years and their culture and strategy align well with what we have developed at Alba," said Salvatore Stile.

Heb James, Partner at Southfield Capital, commented, "We've been following the customs brokerage space for several years now and are fortunate to have been given the opportunity to partner with one of the industry leaders. Alba's remarkable success is due to the team's deep sector expertise and relentless customer service. We see significant growth potential with Alba as the company continues to invest in technology and find new ways to add value to its client base."

Deerpath Capital Management provided debt financing. Finn Dixon & Herling LLP provided legal counsel, and Roll & Harris LLP provided special trade/customs regulatory counsel, to Southfield Capital.

About Southfield Capital
Southfield Capital is a private equity firm that invests in high-growth, lower middle market companies in the outsourced business services sector. The firm targets companies with $4 - 12 million in EBITDA and partners with management to scale the business through a combination of organic and acquisition growth strategies.

For more information, visit Southfield's website and Southfield's LinkedIn.

Our Team
Andy Levison, Managing Partner
Andy Cook, Partner
Heb James, Partner
Tim Lewis, Partner
Brandon Pinderhughes, Principal
Chris Grambling, Principal
Josh Sylvan, Vice President
Logan Vorwerk, Associate
Mike Weber, Associate
Carlson Rainer, VP of Business Development
Jon Goldstein, Chief Financial Officer

Southfield Capital
140 Greenwich Avenue
Greenwich, CT 06830
Phone: 203.813.4100
Fax: 203.813.4141
www.southfieldcapital.com

SOURCE Southfield Capital


These press releases may also interest you

at 07:17
NAPCO Security Technologies, Inc. , one of the leading manufacturers and designers of high-tech...

at 07:15
Flow Capital Corp. ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on...

at 07:10
bluebird bio, Inc. announced today that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET. To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and...

at 07:05
Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2024 and...

at 07:00
Total 1Q 2024 net product revenue of $75.0 million, representing 160% year-over-year growth Auvelity® 1Q 2024 net product sales of $53.4 million, representing 240% year-over-year growth Sunosi® 1Q 2024 net product revenue of $21.6 million...

at 07:00
Brookfield Asset Management ("Brookfield") and Castlelake L.P. ("Castlelake"), an alternatives asset manager specializing in asset-based private credit including aviation and specialty finance, today announced that they have entered into an...



News published on and distributed by: